» Articles » PMID: 17369367

Long-standing Influenza Vaccination Policy is in Accord with Individual Self-interest but Not with the Utilitarian Optimum

Overview
Specialty Science
Date 2007 Mar 21
PMID 17369367
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Influenza vaccination is vital for reducing infection-mediated morbidity and mortality. To maximize effectiveness, vaccination programs must anticipate the effects of public perceptions and attitudes on voluntary adherence. A vaccine allocation strategy that is optimal for the population is not necessarily optimal for an individual. For epidemic influenza, the elderly have the greatest risk of influenza mortality, yet children are responsible for most of the transmission. The long-standing recommendations of the Centers for Disease Control follow the dictates of individual self-interest and prioritize the elderly for vaccination. However, preferentially vaccinating children may dramatically reduce community-wide influenza transmission. A potential obstacle to this is that the personal utility of vaccination is lower for children than it is for the elderly. We parameterize an epidemiological game-theoretic model of influenza vaccination with questionnaire data on actual perceptions of influenza and its vaccine to compare Nash equilibria vaccination strategies driven by self-interest with utilitarian strategies for both epidemic and pandemic influenza. Our results reveal possible strategies to bring Nash and utilitarian vaccination levels into alignment.

Citing Articles

Investigating the impact of environmental feedback on the optional prisoner's dilemma for insights into cyclic dominance and evolution of cooperation.

Shuvo M, Ariful Kabir K R Soc Open Sci. 2024; 11(10):240717.

PMID: 39445094 PMC: 11495962. DOI: 10.1098/rsos.240717.


Gender differences in responses to an altruistic message regarding rubella vaccination.

Okuno H, Satoh H, Arai S, Suzuki M, Kikkawa T Front Public Health. 2024; 12:1353091.

PMID: 39185119 PMC: 11341465. DOI: 10.3389/fpubh.2024.1353091.


The majority of Canadians likely behaved as myopic rationalists rather than success-based learners when deciding on their first dose of COVID-19 vaccine.

Aghaeeyan A, Ramazi P, Lewis M Front Public Health. 2024; 12():1406911.

PMID: 39114515 PMC: 11303299. DOI: 10.3389/fpubh.2024.1406911.


Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine for older adults in South Korea.

Song Y, Shim E Hum Vaccin Immunother. 2024; 20(1):2348124.

PMID: 38714332 PMC: 11085998. DOI: 10.1080/21645515.2024.2348124.


Simple economics of vaccination: public policies and incentives.

Villota-Miranda J, Rodriguez-Ibeas R Int J Health Econ Manag. 2024; 24(2):155-172.

PMID: 38517588 PMC: 11588956. DOI: 10.1007/s10754-024-09367-2.


References
1.
Wilde J, McMillan J, Serwint J, Butta J, ORiordan M, Steinhoff M . Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA. 1999; 281(10):908-13. DOI: 10.1001/jama.281.10.908. View

2.
. Influenza vaccination and self-reported reasons for not receiving influenza vaccination among Medicare beneficiaries aged > or =65 years--United States, 1991-2002. MMWR Morb Mortal Wkly Rep. 2004; 53(43):1012-5. View

3.
Viboud C, Bjornstad O, Smith D, Simonsen L, Miller M, Grenfell B . Synchrony, waves, and spatial hierarchies in the spread of influenza. Science. 2006; 312(5772):447-51. DOI: 10.1126/science.1125237. View

4.
Govaert T, Thijs C, Masurel N, Sprenger M, Dinant G, Knottnerus J . The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 1994; 272(21):1661-5. View

5.
Neuzil K, Dupont W, Wright P, Edwards K . Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatr Infect Dis J. 2001; 20(8):733-40. DOI: 10.1097/00006454-200108000-00004. View